Bioretec Ltd Conducts Extraordinary General Meeting: Major Resolutions Announced #Finland #Helsinki #Bioretec_Ltd #RemeOs #Activa
Bioretec Ltd to Launch Major Rights Issue Aiming for Financial Growth #Finland #Helsinki #Bioretec_Ltd #RemeOs #Stephen_Industries
Bioretec Ltd: Upcoming Rights Issue to Strengthen Capital Base and Fund New Strategy #Finland #Tampere #Bioretec_Ltd #RemeOs #Activa
Shareholders' Nomination Board Proposes Board Members for Bioretec Ltd Annual General Meeting 2026 #Tampere #Board_Members #Nomination_Board #Bioretec_Ltd
Bioretec Ltd's Half-Year Report 2025: Promising Growth After Rights Issue Success #Finland #Tampere #Bioretec_Ltd #RemeOs #Activa
Bioretec Ltd's Rights Issue Success: An Overview and Its Impact on the Market #Finland #Tampere #Medical_Devices #Bioretec_Ltd #Bioretec_RemeOs
Bioretec Ltd Successfully Completes Oversubscribed Rights Issue Raising Over €9 Million #RemeOs™ #Finland #Tampere #Orthopedic_Implants #Bioretec_Ltd
Highlights from Bioretec Ltd's Annual General Meeting and Board Charter Updates #Finland #Tampere #Medical_Devices #Bioretec_Ltd #Bioretec_AG
Bioretec Ltd. convenes Annual General Meeting, Board restructuring and future plans #Finland #Tampere #Medical_Devices #Board_of_Directors #Bioretec_Ltd
Bioretec Ltd Announces Annual General Meeting Details for 2025 #Finland #Tampere #Annual_General_Meeting #Bioretec_Ltd #Financial_Statements
Bioretec Ltd's Shareholders' Nomination Board Proposals for 2025 AGM #Bioretec #Finland #Tampere #Annual_General_Meeting #Bioretec_Ltd